athenahealth (NASDAQ:ATHN) posted its earnings results on Friday. The health services provider reported $0.81 earnings per share for the quarter, beating analysts’ consensus estimates of $0.71 by $0.10, Morningstar.com reports. athenahealth had a net margin of 8.71% and a return on equity of 14.71%. The firm had revenue of $331.40 million during the quarter, compared to analyst estimates of $336.98 million. During the same period last year, the firm posted $0.56 earnings per share. athenahealth’s revenue for the quarter was up 8.8% compared to the same quarter last year. athenahealth updated its FY 2018 guidance to EPS.
Shares of NASDAQ:ATHN traded down $4.53 on Friday, hitting $120.35. 849,908 shares of the company’s stock were exchanged, compared to its average volume of 557,273. athenahealth has a 12 month low of $116.77 and a 12 month high of $163.94. The company has a market cap of $5.12 billion, a price-to-earnings ratio of 76.66, a price-to-earnings-growth ratio of 2.23 and a beta of 0.80. The company has a current ratio of 2.62, a quick ratio of 2.62 and a debt-to-equity ratio of 0.23.
In other news, insider Daniel P. Haley sold 2,204 shares of athenahealth stock in a transaction on Monday, October 1st. The stock was sold at an average price of $127.23, for a total transaction of $280,414.92. Following the completion of the sale, the insider now directly owns 10,555 shares in the company, valued at $1,342,912.65. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Over the last quarter, insiders have sold 2,654 shares of company stock valued at $340,770. Corporate insiders own 2.90% of the company’s stock.
ATHN has been the subject of a number of analyst reports. BidaskClub downgraded athenahealth from a “hold” rating to a “sell” rating in a research report on Wednesday, July 25th. Cowen restated a “hold” rating and issued a $150.00 price target on shares of athenahealth in a research report on Wednesday, August 1st. Canaccord Genuity raised their price target on athenahealth from $125.00 to $160.00 and gave the stock a “hold” rating in a research report on Tuesday, July 31st. Stifel Nicolaus restated a “hold” rating and issued a $140.00 price target (up from $134.00) on shares of athenahealth in a research report on Tuesday, July 31st. Finally, Cantor Fitzgerald restated a “hold” rating and issued a $145.00 price target on shares of athenahealth in a research report on Tuesday, September 18th. One investment analyst has rated the stock with a sell rating, fourteen have issued a hold rating and six have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $153.79.
WARNING: This story was originally posted by BBNS and is the property of of BBNS. If you are viewing this story on another domain, it was illegally stolen and republished in violation of United States and international trademark & copyright law. The correct version of this story can be viewed at https://baseballnewssource.com/2018/11/10/athenahealth-athn-releases-earnings-results-beats-estimates-by-0-10-eps/2973042.html.
athenahealth Company Profile
athenahealth, Inc, together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services.
Featured Article: Price to Earnings Ratio (PE), For Valuing Stocks
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.